General drug use-results survey of Hiyasta tablets (PTCL)
Not Applicable
Recruiting
- Conditions
- Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
- Registration Number
- JPRN-jRCT2031210606
- Lead Sponsor
- Post Marketing Surveillance Post Marketing Surveillance Dept.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 170
Inclusion Criteria
All patients with relapsed or refractory PTCL to whom Hiyasta tablets is administered.
Patients in whom recurrent or refractory peripheral T-cell lymphoma (PTCL) was histologically diagnosed.
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method